David Pinto

4PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 21, 2026
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study.

Maggie Banys-Paluchowski, Steffi Hartmann, Jana de Boniface

|Mar 17, 2023
Correction: Effectiveness of Secondary Risk-Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study.

Jelena Maksimenko, Pedro Pereira Rodrigues, Miki Nakazawa-Miklaševiča

|Dec 29, 2022
Effectiveness of Secondary Risk-Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study.

Jelena Maksimenko, Pedro Pereira Rodrigues, Miki Nakazawa-Miklaševiča

|Apr 03, 2021
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study.

Maggie Banys-Paluchowski, Maria Luisa Gasparri, Jana de Boniface

Pageof 1

Frequent Collaborators

2 joint publications

Jana de Boniface

2 joint publications

Oreste Gentilini

2 joint publications

Eduard-Alexandru Bonci

2 joint publications

Laura Niinikoski